1887

Abstract

The first Dutch outbreak due to ribotype 027 was observed in mid-2005; by the end of that year, eight hospitals were affected. To study the relationship between hospital-wide antibiotic use and the incidence of 027-linked -associated disease (CDAD) three study groups were made: group A, all eight hospitals with an 027-associated epidemic; group B, five of a total of six hospitals with occasional 027 cases, without an increase in CDAD; and group C, ten randomly selected hospitals with no reported 027 epidemics or isolated 027 cases. Quarterly data on CDAD incidences, hygiene measures and the use of fluoroquinolones, second- and third-generation cephalosporins, extended-spectrum penicillins, penicillins with beta-lactamase inhibitors, carbapenems, lincomycins and macrolides were collected for 2004 and 2005, and divided into pre-epidemic and epidemic periods. Using a multilevel Poisson regression analysis, CDAD incidence was linked to antibiotic use in the previous quarter and to certain hygiene measures. In the pre-epidemic period, the total use of the studied antibiotics was comparable between affected and unaffected hospitals. Higher use of second-generation cephalosporins, macrolides and all of the studied antibiotics were independently associated with a small increase in CDAD incidence [relative risk (95 % confidence interval): 1.14 per increase of 100 defined daily doses per 10 000 bed days (1.06–1.23), 1.10 (1.01–1.19) and 1.02 (1.01–1.03), respectively]. However the effect was too small to predict which hospitals might be more prone to 027-associated outbreaks.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47711-0
2008-06-01
2019-12-11
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/6/709.html?itemId=/content/journal/jmm/10.1099/jmm.0.47711-0&mimeType=html&fmt=ahah

References

  1. Barbut, F., Gariazzo, B., Bonne, L., Lalande, V., Burghoffer, B., Luiuz, R. & Petit, J. C. ( 2007; ). Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000–2004. Infect Control Hosp Epidemiol 28, 131–139.[CrossRef]
    [Google Scholar]
  2. Berild, D., Smaabrekke, L., Halvorsen, D. S., Lelek, M., Stahlsberg, E. M. & Ringertz, S. H. ( 2003; ). Clostridium difficile infections related to antibiotic use and infection control facilities in two university hospitals. J Hosp Infect 54, 202–206.[CrossRef]
    [Google Scholar]
  3. Biller, P., Shank, B., Lind, L., Brennan, M., Tkatch, L., Killgore, G., Thompson, A. & McDonald, L. C. ( 2007; ). Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Infect Control Hosp Epidemiol 28, 198–201.[CrossRef]
    [Google Scholar]
  4. Cartmill, T. D., Panigrahi, H., Worsley, M. A., McCann, D. C., Nice, C. N. & Keith, E. ( 1994; ). Management and control of a large outbreak of diarrhoea due to Clostridium difficile. J Hosp Infect 27, 1–15.[CrossRef]
    [Google Scholar]
  5. Chandler, R. E., Hedberg, K. & Cieslak, P. R. ( 2007; ). Clostridium difficile-associated disease in Oregon: increasing incidence and hospital-level risk factors. Infect Control Hosp Epidemiol 28, 116–122.[CrossRef]
    [Google Scholar]
  6. Cherifi, S., Delmee, M., Van Broeck, J., Beyer, I., Byl, B. & Mascart, G. ( 2006; ). Management of an outbreak of Clostridium difficile-associated disease among geriatric patients. Infect Control Hosp Epidemiol 27, 1200–1205.[CrossRef]
    [Google Scholar]
  7. Debast, S. B., Vaessen, N., Choudry, A. & van den Berg, R. & Kuijper E. ( 2006; ). Outbreak of Clostridium difficile PCR-ribotype 027 toxinotype III in Harderwijk, the Netherlands. In Abstracts of the 16th European Congress of Clinical Microbiology and Infectious Diseases. Nice, 1–4 April 2006. Abstract P1640. http://www.blackwellpublishing.com/eccmid16/abstract.asp?id=50435
  8. Fawley, W. N., Underwood, S., Freeman, J., Baines, S. D., Saxton, K., Stephenson, K., Owens, R. C., Jr & Wilcox, M. H. ( 2007; ). Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect Control Hosp Epidemiol 28, 920–925.[CrossRef]
    [Google Scholar]
  9. Gaynes, R., Rimland, D., Killum, E., Lowery, H. K., Johnson, T. M., II, Killgore, G. & Tenover, F. C. ( 2004; ). Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 38, 640–645.[CrossRef]
    [Google Scholar]
  10. Goorhuis, A., Van der Kooi, T., Vaessen, N., Dekker, F. W., Van den Berg, R., Harmanus, C., van den Hof, S., Notermans, D. W. & Kuijper, E. J. ( 2007; ). Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis 45, 695–703.[CrossRef]
    [Google Scholar]
  11. Hubert, B., Loo, V. G., Bourgault, A. M., Poirier, L., Dascal, A., Fortin, E., Dionne, M. & Lorange, M. ( 2007; ). A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis 44, 238–244.[CrossRef]
    [Google Scholar]
  12. Johnson, S. & Gerding, D. N. ( 2004; ). Clostridium difficile. In Hospital Epidemiology and Infection Control, pp. 623–634. Edited by G. M. Mayhall. Philadelphia: Lippincott Williams & Wilkins.
  13. Khan, R. & Cheesbrough, J. ( 2003; ). Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital. J Hosp Infect 54, 104–108.[CrossRef]
    [Google Scholar]
  14. Kuijper, E. J., Debast, S. B., Van Kregten, E., Vaessen, N., Notermans, D. W. & van den Broek, P. J. ( 2005; ). Clostridium difficile ribotype 027, toxinotype III in The Netherlands. Ned Tijdschr Geneeskd 149, 2087–2089.
    [Google Scholar]
  15. Kyne, L., Merry, C., O'Connell, B., Harrington, P., Keane, C. & O'Neill, D. ( 1998; ). Simultaneous outbreaks of two strains of toxigenic Clostridium difficile in a general hospital. J Hosp Infect 38, 101–112.[CrossRef]
    [Google Scholar]
  16. Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A. M., Nguyen, T., Frenette, C. & other authors ( 2005; ). A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353, 2442–2449.[CrossRef]
    [Google Scholar]
  17. McCusker, M. E., Harris, A. D., Perencevich, E. & Roghmann, M. C. ( 2003; ). Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg Infect Dis 9, 730–733.[CrossRef]
    [Google Scholar]
  18. McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Jr, Kazakova, S. V., Sambol, S. P., Johnson, S. & Gerding, D. N. ( 2005; ). An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353, 2433–2441.[CrossRef]
    [Google Scholar]
  19. Modena, S., Bearelly, D., Swartz, K. & Friedenberg, F. K. ( 2005; ). Clostridium difficile among hospitalized patients receiving antibiotics: a case-control study. Infect Control Hosp Epidemiol 26, 685–690.[CrossRef]
    [Google Scholar]
  20. Muto, C. A., Pokrywka, M., Shutt, K., Mendelsohn, A. B., Nouri, K., Posey, K., Roberts, T., Croyle, K., Krystofiak, S. & other authors ( 2005; ). A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 26, 273–280.[CrossRef]
    [Google Scholar]
  21. Muto, C. A., Blank, M. K., Marsh, J. W., Vergis, E. N., O'Leary, M. M., Shutt, K. A., Pasculle, A. W., Pokrywka, M., Garcia, J. G. & other authors ( 2007; ). Control of an outbreak of infection with the hypervirulent Clostridium difficile B1 strain in a university hospital using a comprehensive “bundle” approach. Clin Infect Dis 45, 1266–1273.[CrossRef]
    [Google Scholar]
  22. Notermans, D., van Kregten, E., Speelman, P. & Kuijper, E. ( 2005; ). Maatregelen bij een epidemische verheffing in een ziekenhuis door Clostridium difficile ribotype 027 – toxinotype III. Bilthoven, The Netherlands: Centre for Infectious Disease Control/National Institute for Public Health and the Environment (in Dutch). http://www.rivm.nl/cib/infectieziekten/Clostridium_difficile/Clostridium_difficile_draaiboek.jsp
  23. O'Connor, K. A., Kingston, M., O'Donovan, M., Cryan, B., Twomey, C. & O'Mahony, D. ( 2004; ). Antibiotic prescribing policy and Clostridium difficile diarrhoea. QJM 97, 423–429.[CrossRef]
    [Google Scholar]
  24. Pepin, J., Valiquette, L., Alary, M. E., Villemure, P., Pelletier, A., Forget, K., Pepin, K. & Chouinard, D. ( 2004; ). Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171, 466–472.[CrossRef]
    [Google Scholar]
  25. Pepin, J., Saheb, N., Coulombe, M. A., Alary, M. E., Corriveau, M. P., Authier, S., Leblanc, M., Rivard, G., Bettez, M. & other authors ( 2005; ). Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41, 1254–1260.[CrossRef]
    [Google Scholar]
  26. Salgado, C., Fogle, P., Harley, B., Mauldin, P., Bosso, J. & Cantey, J. ( 2006; ). Clostridium difficile associated diarrhea outbreak controlled with enhanced infection control measures. In Abstracts of the 16th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America. Chicago, 18–21 March 2006. Abstract 190.
  27. Shek, F. W., Stacey, B. S., Rendell, J., Hellier, M. D. & Hanson, P. J. ( 2000; ). The rise of Clostridium difficile: the effect of length of stay, patient age and antibiotic use. J Hosp Infect 45, 235–237.[CrossRef]
    [Google Scholar]
  28. Siegel, J. D., Rhinehart, E., Jackson, M., Chiarello, L. & The Healthcare Infection and Control Practices Advisory Committee ( 2007; ). Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings 2007. Atlanta, GA: Public Health Service, US Department of Health and Human Services, Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/dhqp/pdf/Isolation2007.pdf
  29. SWAB ( 2007; ). NETHMAP 2007 – Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in The Netherlands. Bilthoven, The Netherlands: RIVM and Stichting Werkgroep Antibioticabeleid. http://www.swab.nl/swab/swabcms.nsf/(WebFiles)/D552D3B6190D0461C12572FF0024F246/$FILE/NETHMAP_2007.pdf
  30. Valiquette, L., Cossette, B., Garant, M. P., Diab, H. & Pepin, J. ( 2007; ). Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 45 (Suppl. 2), S112–S121.[CrossRef]
    [Google Scholar]
  31. Veenendaal, D. & Kuijper, E. ( 2007; ). Successful combat against Clostridium difficile PCR-ribotype 027 at a regional outbreak from 2003–2006 in the Netherlands. In Abstracts of the 17th European Congress of Clinical Microbiology and Infectious Diseases. Munich, 31 March–4 April 2007. Abstract 1732_216. http://www.blackwellpublishing.com/eccmid17/abstract.asp?id=56178
  32. Warny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., Frost, E. & McDonald, L. C. ( 2005; ). Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366, 1079–1084.[CrossRef]
    [Google Scholar]
  33. Weil, H.-P., Mattner, F., van den Berg, R., Gastmeier, P., Kuijper, E. & Fischer-Brügge, U. ( 2007; ). Characterisation and management of healthcare onset Clostridium difficile associated diarrhoea in a hyperendemic region in Germany. In Abstracts of the 17th European Congress of Clinical Microbiology and Infectious Diseases. Munich, 31 March–4 April 2007. Abstract 1733_1419. http://www.blackwellpublishing.com/eccmid17/abstract.asp?id=57718
  34. Zafar, A. B., Gaydos, L. A., Furlong, W. B., Nguyen, M. H. & Mennonna, P. A. ( 1998; ). Effectiveness of infection control program in controlling nosocomial Clostridium difficile. Am J Infect Control 26, 588–593.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47711-0
Loading
/content/journal/jmm/10.1099/jmm.0.47711-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error